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SUMMARY
In a cross-sectional survey of 226 HIV-infected men, we examined the occurrence of diarrhoea
and its relationship to drinking water consumption patterns, risk behaviours, immune status
and medication use. Diarrhoea was reported by 47 % of the respondents. Neither drinking
boiled nor filtered water was significantly associated with diarrhoea (OR ¯ 0±5 [0±2, 1±6], 1±2
[0±6, 2±5] respectively), whereas those that drank bottled water were at risk for diarrhoea (OR
¯ 3±0 [1±1, 7±8]). Overall, 47 % always or often used at least one water treatment. Of the 37 %
who were very concerned about drinking water, 62 % had diarrhoea, 70 % always or often
used at least one water treatment. An increase in CD4 count was protective only for those
with a low risk of diarrhoea associated with medication (OR ¯ 0±6 [0±5, 0±9]). A 30 %
attributable risk to diarrhoea was estimated for those with high medication risk compared to
those with low medication risk. The significant association between concern with drinking
water and diarrhoea as well as between concern with drinking water and water treatment
suggests awareness that drinking water is a potential transmission pathway for diarrhoeal
disease. At the same time we found that a significant portion of diarrhoea was associated with
other sources not related to drinking water such as medication usage.

INTRODUCTION
Diarrhoea is a common problem for HIV-infected
individuals and may be due to both infectious and
non-infectious causes. An important and increasing
non-infectious cause of diarrhoea is related to effects
due to medications that are prescribed to HIVinfected individuals. In particular, the incidence of
medication-related diarrhoea has increased since the
* Author for correspondence : 140 Warren Hall, MC 7360, School
of Public Health, University of California, Berkeley, CA 947207360, USA.

introduction of highly active antiretroviral therapy
(HAART) in the last quarter of 1996 [1]. Common
infectious causes of diarrhoea include viral, bacterial
and protozoan pathogens [2–4]. The impact of these
diseases has been well documented. For example,
prior to the introduction of HAART, one of the most
serious of the protozoan infections was caused by
Cryptosporidium, which was chronic in 10–15 % of
AIDS patients, 50 % of whom died of cryptosporidiosis [5]. Other enteric pathogens with similar
routes of exposure have been implicated as causes of
diarrhoea in HIV-infected individuals, such as Giardia
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[6, 7], enteric viruses [8], Microsporidia [9] and
adenovirus [10]. There are, however, few data collected after the introduction of HAART with which to
estimate the relative epidemiological significance of
these non-infectious and infectious causes of diarrhoea. To understand better the contribution of
these pathways to the overall incidence of diarrhoea,
we conducted a cross-sectional survey to measure
various risk factors and their association with gastrointestinal symptoms, with a particular emphasis on
drinking water exposure.
We focus on drinking water risks because there is
heated debate in the United States about the extent to
which waterborne infectious diseases may be transmitted to human beings through drinking water which
has met federal standards for pathogen removal [11,
12]. Studies in Canada suggested that approximately
35 % of endemic gastrointestinal illness in a community might be due to drinking water [13, 14].
Outbreaks of disease linked to public water supplies
with and without known lapses in water treatment [15,
16] have resulted in a number of deaths, the majority
of which were in HIV-infected individuals. Because of
these findings, Centers for Disease Control and
Prevention (CDC) guidelines for persons with immunocompromising conditions suggest that boiling
water is an effective strategy to lower such risks. It is
difficult to evaluate how widely these guidelines are
followed by HIV-infected individuals or to measure
how effective they are in reducing risk.
Very little data, however, exist on drinking-water
risks in non-outbreak conditions. Two recently published cross-sectional surveys have focused on
drinking water behaviour in an HIV-infected population, one conducted in San Francisco [17] and the
other in New York [18]. Although both studies
contained important findings, neither addressed the
association of risk factor behaviour with disease
status. Kim et al. [17] explored how risk perception
affects risk behaviour, while Davis et al. [18],
compared risk behaviour between an HIV-infected
cohort and an immunocompetent cohort.
To improve our understanding of disease transmission associated with enteric pathogens, we conducted a cross-sectional survey among HIV-infected
patients at the San Francisco Veterans Administration
Medical Center (SFVAMC), between October 1998
and June 1999. Our objectives were to estimate : (1)
the prevalence of diarrhoea among HIV-infected
individuals ; (2) the degree to which drinking water
habits are associated with gastrointestinal illness ; and

(3) the attributable risk of diarrhoea associated with
medication risk.

MATERIALS AND METHODS
Data collection and analysis
We administered a questionnaire to patients attending
the ID}AIDS clinic at the San Francisco Veterans
Administration Medical Center (SFVAMC), between
18 October 1998 and 1 June 1999. Those agreeing to
participate signed the informed consent form and then
were given the survey to complete. The study
instrument was approved by the Institutional Review
Boards from the University of California at Berkeley,
the University of California at San Francisco, and the
Center for Disease Control and Prevention. The
survey addressed specific drinking water behaviours,
medication use, CD4 count, and other risk factors for
gastrointestinal illness.
The survey included questions on : (1) drinking
water behaviour ; (2) other risk factors for diarrhoeal
disease such as medication, sexual practice, food,
contact with animals, travel, etc. ; (3) self-reported
symptoms ; (4) demographic information (age, race
and income) ; and (5) knowledge and attitudes of
drinking water risks. In addition, clinical records of
CD4 count and medication use were obtained from a
chart review of the patients. The outcome variable,
diarrhoea, was defined as the presence of two or
more loose or unformed stools in a day. The patient
answered yes or no to whether they had experienced
diarrhoea in the last 7 days.
Since each patient on average took several medications, each with a different risk of diarrhoea due to
side effects, we developed a continuous scale to
estimate the overall diarrhoeal risk associated with
possible medication side effects. Each drug was
assigned a percent probability of diarrhoea value
based on published information [1]. Medications that
had no known diarrhoeal side effects were assigned a
probability of diarrhoea of 0. Medications producing
diarrhoeal side effects between 0 and 1 % of the time
were assigned a probability of 0±01. Medications
producing diarrhoeal side effects between 1 and 10 %
were assigned a 0±1 probability of diarrhoea, and
medications with more 10 % diarrhoeal side effects
were assigned a probability of 0±2 [l]. Assuming that
each drug acted independently in producing diarrhoeal side effects, and that P , P , …, Pm were the
" #
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Table 1. Association of risk factors with diarrhoea for the categorical ariables
n (with
diarrhoea)
Drinking water
Heard of CDC drinking water guidelines?
Yes
No
How concerned about drinking
water and its health effects?
Not at all concerned
A little concerned
Very concerned
Always or often uses at least one type
of water treatment?
Yes
No
How often drinks boiled water?
Never
Rarely
Sometimes
Often
Always
How often drinks bottled water?
Never
Rarely
Sometimes
Often
Always
How often drinks filtered water?
Never
Rarely
Sometimes
Often
Always
Medications
Number of medications with greater than
10 % diarrhoeal side effects
0
1
2
3
4
5
Any medications with greater than 10 %
diarrhoeal side effects
Yes
No
Taken any medications in the past 6-months
Yes
No
Immune status
CD4 &500
CD4 ! 500
Pets and animal contact
Have any pets at home?
Yes
No

n (without
diarrhoea)

OR (95 %CI)

P-value*

23
82

18
95

1±5 (0±8–2±9)
1±0 (reference)

0±30

13
35
37

32
39
23

1±0 (reference)
2±1 (1±0–4±8)
4±0 (1±7–9±0)

0±004†
0±056
0±0015

57
48

48
72

1±8 (1±1–3±0)
1±0 (reference)

0±044

78
11
5
2
5

85
8
5
3
10

1±0 (reference)
1±5 (0±6–3±8)
1±1 (0±3–3±7)
0±7 (0±0–3±7)
0±5 (0±2–1±6)

0±7†
0±47
1±00
1±00
0±42

10
30
26
17
21

24
32
27
18
17

1±0 (reference)
2±3 (0±9–5±4)
2±3 (0±9–5±7)
2±3 (0±9–6±0)
3±0 (1±1–7±8)

0±245†
0±086
0±079
0±14
0±034

62
6
7
10
17

73
11
9
6
17

1±0 (reference)
0±6 (0±2–1±8)
0±9 (0±3–2±5)
2±0 (0±7–5±5)
1±2 (0±6–2±5)

0±6†
0±45
1±00
0±29
0±70

40
43
13
4
0
1

69
37
13
0
0
0

2±0 (1±1–3±6)
1±7 (0±7–4±0)

0±019†
0±0026
0±26

61
40

50
69

2±1 (1±2–3±6)
1±0 (reference)

0±007

95
6

104
15

2±3 (0±9–5±9)
1±0 (reference)

0±11

16
82

39
73

0±4 (0±2–0±7)
1±0 (reference)

0±0027

45
57

47
70

1±2 (0±7–2±0)
1±0 (reference)

0±58

75

76

J. N. S. Eisenberg and others

Table 1 (cont.)
n (with
diarrhoea)
Clean pet’s urine?
Yes
No
Any contact with farm animals
Yes
No

n (without
diarrhoea)

OR (95 %CI)

P-value*

30
70

23
93

1±7 (0±9–3±2)‡
1±0 (reference)

0±11

6
94

3
114

2±4 (0±7–9±1)
1±0 (reference)

0±31

* 2-sided Fisher’s exact test except where noted by a † the χ# test of association for whole table was calculated.
‡ For those with CD4 ! 200 : OR ¯ 4±0 (1±1–14±3).

probabilities associated with each of the m drugs taken
by a given individual, the medication risk metric
(MRM) was calculated as follows :
MRM ¯ 1®[(1®P ) (1®P ) … (1®Pm)].
"
#
For the purposes of estimating attributable risk, the
variable medication risk was categorized into four
groups : 0–0±2, 0±2–0±4, 0±4–0±6 and 0±6–0±8. We
estimated attributable risk as :
Pn(D)®Pn(DrE )
,
Pn(D)
where Pn(D) was the overall proportion of diarrhoea,
and Pn(DrEN ) the proportion of disease among the
low risk.
The associations between the risk factors included
in the survey and symptoms of diarrhoea were
assessed using bivariate tabulations and calculations
of odds ratios. To account for variation in diarrhoea
at different levels of CD4 and medication use, adjusted
odds ratios were also calculated from a logistic model.
The outcome was a bivariate indicator of diarrhoeal
incidence in the past 7 days and the covariates in this
model included CD4 and medication risk. A term
describing the interaction between CD4 and medication risk was also included in the model. The data
were entered and organized in Access97 (Microsoft2),
and Stata (Version 6.0, Stata Corporation).

RESULTS
In this study 226 patients (77 %) of the 305 who were
approached completed the survey. All participants
were HIV-infected males (68 % were diagnosed with
AIDS) with a median age of 49. The racial breakdown

was : 152 Whites (68 %), 43 Blacks (19 %), 19
Hispanics (8 %), and 11 other (5 %). The socioeconomic status was that of low income (68 % earned
! $20 000 per year), high unemployment (70 %), and
on average 2 years of post high school education.
Among demographic characteristics, only age was
associated with diarrhoea. Those with diarrhoea were
slightly younger (mean ¯ 47±8) than those without
diarrhoea (50±5) (P ¯ 0±058).
Forty-seven percent of the participants reported
diarrhoea in the preceding 7 days, the principal
outcome measure of the study. Table 1 contains the
risk factors included in the survey and their association with diarrhoea. In this section we report our
analysis of the survey in three parts : first, we present
drinking water risk factors associated with diarrhoea ;
second we introduce the factors obtained from clinical
records, such as medication use and CD4 count, and
present calculations for the attributable risk of
diarrhoea from medication ; and finally we present all
other risk factors contained in the survey and present
calculations of their association to diarrhoea.

Drinking water risk factors associated with diarrhoea
Although most participants were unaware of the CDC
drinking water guidelines for HIV-infected individuals
that advise boiling drinking water (81 %), 34 % were
very concerned and 75 % were at least a little
concerned about the health effects of drinking tap
water. The association between concern about water
and diarrhoea was significant : the odds of diarrhoea
were fourfold higher among those concerned about
drinking water compared to those without this
concern (OR ¯ 4±0 [1±7, 9±0]).
Participants responded that they always or often
treated their water (by drinking boiled, filtered or

GI illness in HIV-infected patients

77

Table 2. Association of risk factors with diarrhoea for the continuous ariables

Demographic characteristics
Age
Drinking water
Percent of drinking water treated
Glasses of tapwater per day at home
Total glasses of tapwater per day
Medications
Probability of diarrhoea from medication
Health
CD4

With diarrhoea

Without diarrhoea

n

Mean (SD)

Mean (SD)

P

221

47±8 (10±3)

50±5 (10±9)

0±058

213
216
224

52 (39)
4±4 (4±0)
6±7 (5±5)

46 (41)
4±3 (3±9)
5±5 (5±5)

0±31
0±89
0±77

221

0±36 (0±15)

0±30(0±16)

0±005

211

352 (228)

413 (241)

0±059

bottled water) 47 % of the time. Always or often
treating water was positively associated with diarrhoea in the last 7 days (OR ¯ 1±8 [1±0, 3±0]).
Stratifying by treatment strategy, 9 % responded
always or often to boiling their water, 23 % to filtering
their water, and 33 % to drinking bottled water. The
odds of diarrhoea in the past 7 days were lower among
those who always boil their water (OR ¯ 0±5 [0±2,
1±6]). The precision of the estimate was limited since
few participants boiled drinking water (power calculations suggest that a sample size of 520 would be
needed to achieve 80 % power). In comparison,
drinking bottled water showed a trend towards being
a risk factor (P ¯ 0±068). Those who always used
bottled water were nearly three times as likely to have
experienced diarrhoea in the past 7 days (OR ¯ 3±0
[1±1–7±8]).
The odds of always or often drinking either boiled,
filtered or bottled water was over 8 times greater for
those who were very concerned about water compared
to those who were not concerned about water (OR ¯
7±5 [2±1–27±1]), suggesting that those who were
concerned about their drinking water were acting
upon their concerns.
Medication and CD4 count
CD4 count was in the range 1–1000 with one case
above 1400. The mean and median were around 385
and 359 respectively. The association of CD4 count
greater than 500 with diarrhoea was significant
(OR ¯ 0±4 [0±2, 0±7]).
The medication risk was in the range 0–0±71 with a
mean and median of 0±33. The association between
diarrhoea in the last 7 days and taking medication

with " 10 % risk of diarrhoea was significant (OR ¯
2±1 [1±2, 3±6]). Comparing the observed risk (proportion with diarrhoea obtained from the survey
data) with our predicted risk (calculated for the
medication risk variable) we found that a 0–0±2
medication risk was associated with a 0±3 prevalence
of diarrhoea, a 0±2–0±4 medication risk was associated
with a 0±4 prevalence, a 0±4–0±6 medication risk was
associated with a 0±4 prevalence, and 0±6–0±8 medication risk was associated with a 0±4 prevalence.
Clinical evidence suggests that there is an interaction between medication usage and CD4 count,
since HAART medication both causes diarrhoea
directly due to side effects and decreases the risk of
infectious diarrhoea indirectly by increasing a
patient ’s CD4 count. When an interaction term for
CD4 count and medication risk was included in a
logistic model a significant interaction was reflected in
the data. Only for low medication risks (! 0±21) was
CD4 count protective (OR ¯ 0±6 [0±5, 0±9]), for an
increase of 100 in CD4 count. For high medication
risk (" 0±21) increasing CD4 count was not protective.
The association of diarrhoea and medication risk
group was calculated by grouping participants into a
low medication risk group (0–0±21), a medium risk
group (0±21–0±43), and a high-risk group (" 0±43). The
proportions of subjects with diarrhoea was 0±58 for
medication risk " 0±43, 0±46 for medication risk
between 0±21 and 0±43, and 0±33 for medication risk
! 0±21. Using the low medication risk group as the
baseline (unexposed), the odds ratio for the medium
risk group was 1±7 (0±9, 3±4) and for the high risk
group was 3±6 (1±2, 6±3). Based on our 0±47 estimate for
overall probability of diarrhoea, the attributable risk
due to medication use was 0±3 ((0±47–0±33)}0±47).
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There was also an association (of borderline
statistical significance) between CD4 count and
boiling drinking water. We found that those who
never boil their water had a higher CD4 count (407)
than those that always or often boiled their water
(297) (P-value ¯ 0±08, t test for difference between
means).
Other risk factors for diarrhoea
Diarrhoea in the last 7 days was statistically unrelated
to sexual contact and to specific high-risk sexual
behaviours. However, the point estimates for anal
contact (OR ¯ 0±8 [0±5, 1±4]) and contact with women
(0±4 [0.l, 1±41]) indicated these factors were associated
with a decreased risk of diarrhoea and sexual contact
with men was associated with an increased risk of
diarrhoea. No relationship was observed between
selected foods and diarrhoea (P " 0±25). Exposure to
pets and other animals was associated with increased
risk of diarrhoea. Contact with farm animals was
associated with diarrhoea (OR ¯ 2±4 [0±6–l0±0]), however, the precision of this estimate was limited since
few subjects (4±1 %) had contact with farm animals.
Cleaning up after pets was also positively associated
with risk of diarrhoea (OR ¯ 1±7 [0±9–3±3]), and was of
borderline statistical significance. This relationship
was stronger and statistically significant among those
with CD4 counts less than 200 (OR ¯ 4±0 [1±1–14±3]).
DISCUSSION
Overall 47 % reported that they always or often treat
their drinking water. This estimate is comparable to
the finding by Kim et al. (1988) that 51 % never or
rarely drank tap water, but a higher value than
reported by Davis et al. (1988), who found that only
18 % of their HIV-infected cohort drank no tap water.
The Davis study also collected data from a non-HIVinfected cohort, which reported 31 % tap water
avoidance. Comparing the frequency of specific water
treatments, Davis et al. estimated that their HIVinfected cohort was drinking boiled and bottled water
approximately twice as often as in our study, and they
were drinking filtered water approximately 2±5 times
less. The increase in the estimate of filter-use from the
time of the Davis et al. study to our current study may
be due to the increasing popularity of home drinking
water filter devices, or may have been due to the fact
that our study and the Davis et al. study did not use
identical questions.

Of the 37 % who were very concerned about
drinking water, 62 % had diarrhoea (compared to
47 % overall), 70 % always or often used at least one
water treatment (compared to 47 % overall). This
significant association between concern about
drinking water and water treatment was also found by
Kim et al. (1998). Therefore, even with limited
knowledge of the CDC guidelines our data suggest a
high level of concern with water quality, especially for
those with diarrhoea.
Although a high level of concern with water quality
may suggest a causal linkage between drinking water
and diarrhoeal disease, analysis of our survey data
indicate that pathways other than drinking water also
may be important in the transmission of infectious
diarrhoea in HIV-infected individuals. In particular,
analysis of our data suggests that exposures to pets
may account for a significant proportion of diarrhoea
in individuals with highly compromised immune
condition (CD4 ! 200), i.e. those who may be
particularly at risk of infectious diarrhoea. This result,
however, is based on data from only a few individuals.
Consistent with our result that the data had suggestive
correlations with certain high-risk exposures to
animals (farm animals, cleaning up urine) and
diarrhoea, another study has recently found that HIVinfected individuals with cryptosporidiosis were
slightly more likely to own dogs as pets [19].
The evidence for statistical interaction between
medication use and CD4 count for diarrhoea risk
suggests that some of these other pathways of
diarrhoea are of infectious origin. For patients with
low medication risks, CD4 count was protective
(associated with decreased diarrhoea), whereas for
those patients with high medication risk, CD4 count
was not protective. One interpretation for this
observation is that patients with high medication risk
were predominately at greater risk for diarrhoea from
a noninfectious cause such as medication use. Those
with low medication risk were, conceivably, at greater
risk for infectious diarrhoea, and therefore, an
increase in CD4 count was protective. This finding has
important public health implications because appropriate intervention depends on knowing the cause
of diarrhoea. Additional information useful for policy
decisions would be data on the differential in the
severity of infectious diarrhoea compared with that
due to noninfectious causes such as medication.
Unfortunately, in this survey we did not collect the
disease severity data needed to address this issue.
Although an attributable risk of 30 % suggests that
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Fig. 1. Causal model diagram linking concern with drinking water quality, water treatment, self-reported diarrhoea,
medication risk and CD4 count. The odds ratios listed were estimated from the survey. The directions of the arrows are
hypothesized by the authors.

medication was a major cause of noninfectious
diarrhoea in our HIV  cohort, there were still 70 %
of diarrhoea cases that were due to other causes. One
such causal pathway could involve drinking water.
Our data suggest certain water treatments, e.g., boiling
water, may be associated with a lower risk of
diarrhoea ; however, analysis of our limited sample
did not confirm a significant association between any
of the water treatment practices and diarrhoea.
Boiling water, the practice that was presumed to be
the most effective against drinking water risk, may
have lacked a significant association because of the
small number of people that actually boiled their
water. One water treatment practice, drinking bottled
water, was found to be a risk factor. The lack of a
statistically significant association for drinking boiled
water and the finding that drinking bottled water was
a risk, may be due, in part, to the existence of the
causal loop postulated in Figure 1, linking concern
with water quality, water treatment, and diarrhoea.
Though cross-sectional studies can provide valuable
descriptive information, they are often limited in
providing unbiased estimates of association. This
limitation is due in part to the lack of temporally
based data, e.g. ‘ Did you boil your water after having
a case of diarrhoea or before? ’. In the absence of such
information, structural assumptions on causality
explicitly provide for a framework to assess consequences of these causal relationships with respect to
risk estimates. Therefore, causal models in conjunction with cross-sectional data can be useful in
postulating possible causal inferences and suggesting
an improved study design that can alleviate some of
the confounding issues. For example, temporal in-

formation can be included to assess a causal inference
both by periodic surveys over time or incorporating
questions that elucidate temporal patterns.
To address these possible biases inherent with risk
estimates made from data collected in cross-sectional
surveys, we postulated the existence of causal linkages
to explicitly define our conceptualization of the
relationship among various factors. The resulting
causal diagram was used to motivate the direction of
potential biases (Fig. 1). Linkages I, II and III
represent the fact that increased diarrhoea can result
in a concern of drinking water quality, which in turn
will result in increased water treatment (such as
boiling water), which in turn can decrease the
prevalence of diarrhoea.
Therefore, an individual may treat water because
they are experiencing diarrhoea, even though the
diarrhoea may have another cause such as medication
use. The existence of this causal loop suggests that a
standard odds ratio estimate will underestimate the
protective level that boiling water has on the prevalence of diarrhoea and overestimate the risk associated
with drinking bottled water, since at least some of the
diarrhoea will not be of infectious origin. One such
example of noninfectious diarrhoea is made explicit in
our causal diagram by linkage IV, the increase of
diarrhoea due to side effects from medication use. The
estimate of attributable risk due to medication use will
potentially be biased due to the confounding effects of
CD4 count. This is illustrated in Figure 1 by linkage
V and VI. Linkage V reflects that fact that one’s CD4
count will influence a physician’s decision to use
antiretroviral medication, and the medication itself
will affect CD4 count. Linkage VI reflects the fact that
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a low CD4 count will increase an individual’s
susceptibility to infectious enteric pathogens.
The complexities of these pathways are illustrated
by the dual role of medication in both decreasing the
rate of infectious diarrhoea by increasing CD4 count,
and increasing the rate of diarrhoea due to side effects.
The observed association between CD4 count and
boiling water is also consistent with this causal
diagram. In this model, a low CD4 count results in an
increase in diarrhoea, which results in an increase in
concern with water quality, which results in an increase
in boiling water (Fig. 1). Therefore, diarrhoea and
concern with drinking water are in the causal pathway
that connects CD4 count with boiling water.
Kim et al. (1998) also found that diarrhoeal
symptoms were often perceived as water-related. In
their study, they demonstrated with an HIV cohort
that perception of risk to enteric pathogens was
significantly associated with boiling water but not
with other potential risk factors such as sexual
practice. These findings are not surprising in light of
the focus on drinking water risks by federal agencies
and the media. Public health education should expand
to address the significant risks of diarrhoea from other
causes in addition to drinking water. In our survey we
did ask about risk factor behaviour, such as sexual
practice, but found no significant association. One
explanation for the lack of significance associated
with sexual practice is that our cohort was on average
older (mean age ¯ 49) than the age profile of HIV
cohorts in both studies by Kim et al. (1998), mean
age ¯ 38, and Davis et al. (1998), mean age ¯ 41.
To better estimate the real effects of water treatment
on diarrhoea, one would need temporal information
to ascertain whether or not, for example, water
treatment and medication use relate to diarrhoea as
we have postulated in Figure 1. Therefore, additional
carefully designed cross-sectional studies or longitudinal cohort studies are needed to validate our
causal model, and to delineate the causal pathways of
diarrhoeal disease.
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